Immunocore Holdings PLC
NASDAQ:IMCR

Watchlist Manager
Immunocore Holdings PLC Logo
Immunocore Holdings PLC
NASDAQ:IMCR
Watchlist
Price: 36.8 USD 2.79% Market Closed
Market Cap: 1.9B USD

Wall Street
Price Targets

IMCR Price Targets Summary
Immunocore Holdings PLC

Wall Street analysts forecast IMCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMCR is 69.09 USD with a low forecast of 36.36 USD and a high forecast of 105 USD.

Lowest
Price Target
36.36 USD
1% Downside
Average
Price Target
69.09 USD
88% Upside
Highest
Price Target
105 USD
185% Upside
Immunocore Holdings PLC Competitors:
Price Targets
IVVD
Invivyd Inc
222% Upside
KALV
Kalvista Pharmaceuticals Inc
87% Upside
IKT
Inhibikase Therapeutics Inc
364% Upside
NBIX
Neurocrine Biosciences Inc
16% Upside
ALT
Altimmune Inc
259% Upside
ORKA
Oruka Therapeutics Inc
58% Upside
ARWR
Arrowhead Pharmaceuticals Inc
15% Downside
068270
Celltrion Inc
19% Upside

Revenue
Forecast

Revenue Estimate
Immunocore Holdings PLC

For the last 5 years the compound annual growth rate for Immunocore Holdings PLC's revenue is 65%. The projected CAGR for the next 4 years is 22%.

65%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Immunocore Holdings PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Immunocore Holdings PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMCR's stock price target?
Price Target
69.09 USD

According to Wall Street analysts, the average 1-year price target for IMCR is 69.09 USD with a low forecast of 36.36 USD and a high forecast of 105 USD.

What is Immunocore Holdings PLC's Revenue forecast?
Projected CAGR
22%

For the last 5 years the compound annual growth rate for Immunocore Holdings PLC's revenue is 65%. The projected CAGR for the next 4 years is 22%.

Back to Top